GlassScriptPhysician profile
Roger M Katz
NPI 1083721344
$1,996.53
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,569 · 2020: $226 · 2021: $127 · 2022: $61.26 · 2023: $13.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $304.75 | 2019-2020 | |
| Glaxosmithkline, LLC. | $253.93 | 2019-2020 | |
| Optinose US, INC. | $183.20 | 2019-2020 | |
| Octapharma USA, INC. | $154.48 | 2019-2021 | |
| Alk-Abello, INC | $138.26 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $138.01 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $123.03 | 2019-2021 | |
| Csl Behring | $120.11 | 2019 | |
| Novartis Pharmaceuticals Corporation | $102.78 | 2019 | |
| Grifols USA, LLC | $82.08 | 2019-2020 | |
| Pfizer INC. | $71.16 | 2019-2023 | |
| Genentech USA, INC. | $58.44 | 2019 | |
| Genzyme Corporation | $46.39 | 2019 | |
| Mylan Specialty L.P. | $43.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.50 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $30.33 | 2019 | |
| Sunovion Pharmaceuticals INC. | $29.63 | 2019 | |
| Amgen INC. | $26.78 | 2022 | |
| Shire North American Group INC | $22.90 | 2019 | |
| Electromed, INC. | $18.99 | 2022 | |
| Kaleo, INC. | $17.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.